Published in
American Association for the Advancement of Science, Science Translational Medicine, 554(12), 2020
DOI: 10.1126/scitranslmed.aaz3339
Links
Tools
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma
Journal article published in 2020 by
Premal D. Lulla 
,
Ifigeneia Tzannou,
Spyridoula Vasileiou,
George Carrum,
Carlos A. Ramos ,
Rammurti Kamble,
Tao Wang,
Mengfen Wu,
Mrinalini Bilgi,
Adrian P. Gee ,
Shivani Mukhi,
Betty Chung ,
Linghua Wang ,
Ayumi Watanabe,
Manik Kuvalekar
and other authors.
,
Ifigeneia Tzannou,
Spyridoula Vasileiou,
George Carrum,
Carlos A. Ramos ,
Rammurti Kamble,
Tao Wang,
Mengfen Wu,
Mrinalini Bilgi,
Adrian P. Gee ,
Shivani Mukhi,
Betty Chung ,
Linghua Wang ,
Ayumi Watanabe,
Manik Kuvalekar
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Infusions of autologous T cells specific for multiple tumor antigens were safe and induced responses in some patients with multiple myeloma.